United States: A warning has been issued by a recent research which warns against the malignant effects on human bodies by the BPA, in terms of raising the risk of developing diabetes disease. 

More about the finding 

The researchers noted that the people who fed small-sized doses of Bisphenol A (BPA) developed a major worsening insulin sensitivity within a span of four days. 

According to the researcher Todd Hagobian, who is the chair of kinesiology and public health at California Polytechnic State University, “We were surprised to see that reducing BPA exposure, such as using stainless steel or glass bottles and BPA-free cans, may lower diabetes risk,” as US News reported. 

For the study purposes, scientists performed tests with a “safe dose” for BPA as set by the US Food and Drug Administration (FDA), whose size amounts to 50 micrograms for each kilogram of body weight. 

BPA Chemical in Consumer Products Tied to Diabetes Risk. Credit | Getty Images
BPA Chemical in Consumer Products Tied to Diabetes Risk. Credit | Getty Images

Know more about BPA 

BPA is a chemical used in the manufacturing of a variety of consumer products such as baby bottles, food containers, tableware, etc. 

Additionally, BPA is maliciously known for disrupting hormone levels in humans, which contributes to raising type 2 diabetes. 

For decades, the negative effects of BPA on humans have raised a growing concern. In 2012, the FDA even banned the usage of BPA in baby bottles and sippy cups because of the effect the chemical might have on child developmental growth, as US News reported. 

However, the FDA has even mentioned that “the available information continues to support the safety of BPA for the currently approved uses in food containers and packaging,” as written on its website. 

How was the study conducted? 

For the study, the scientific team employed 40 healthy and young adults. Among them, half were administered with oral BPA at the DA’s safe level for four days, or a placebo. 

There was no major change in body weight, and blood sugar levels were noted over the span of the next four days between the two groups. 

However, the level of insulin significantly lowered in the BPA group, as compared to the control group. 

Hagobian added, “These results suggest that maybe the U.S. EPA safe dose should be reconsidered and that healthcare providers could suggest these changes to patients,” as US News reported. 

The research findings were presented at the American Diabetes Association’s annual meeting in Orlando, Fla. 

According to Dr. Robert Gabbay, chief scientific and medical officer of the American Diabetes Association, “With the increase in diabetes in the U.S., it is our duty to ensure safety within our products and in our homes.” 

“This is only the beginning of highlighting the need for informed public health recommendations and policies,” Gabby added. 

LEAVE A REPLY

Please enter your comment!
Please enter your name here